Beneficial Effects of Rosmarinus Officinalis for Treatment of Opium Withdrawal Syndrome during Addiction Treatment Programs: A Clinical Trial
Open Access
- 5 February 2014
- journal article
- Vol. 5, 90-94
Abstract
Withdrawal syndrome may influence patient's motivation for participation in addiction treatment programs. Management of the symptoms can improve the success rate of addiction treatment programs. In the present study, we have evaluated the efficiency of an herbal product as adjunct therapy for alleviation of withdrawal syndrome in opium abuse. In the present clinical trial, 81 patients were assigned into case and control groups. The control group was treated with methadone and placebo for 4 weeks. The case group was treated with methadone and powdered dried leaves of Rosmarinus officinalis for the same interval. Occurrence of withdrawal syndrome was compared between groups on days 3, 7, and 14 after beginning of the treatment, and the possible signs and symptoms of withdrawal syndrome were checked. The clinical opioid withdrawal scale (COWS) was used for evaluation of withdrawal syndrome in the patients. Patients in the case group experienced less severe withdrawal syndrome compared to those in the control group; chiefly bone pain, perspiration, and insomnia. The present study showed that rosemary can be used as an optional extra drug for treatment of withdrawal syndrome during treatment programs for opium addiction and possibly addiction to other opioids.Keywords
This publication has 9 references indexed in Scilit:
- Polyphenols from the Mediterranean herb rosemary (Rosmarinus officinalis) for prostate cancerFrontiers in Pharmacology, 2013
- Antidepressant-like effect of ursolic acid isolated from Rosmarinus officinalis L. in mice: Evidence for the involvement of the dopaminergic systemPharmacology Biochemistry and Behavior, 2012
- An analytical and theoretical approach for the profiling of the antioxidant activity of essential oils: The case of Rosmarinus officinalis L.Journal of Pharmaceutical and Biomedical Analysis, 2011
- A Pilot trial evaluating meta050, a proprietary combination of reduced iso-alpha acids, rosemary extract and oleanolic acid in patients with arthritis and fibromyalgiaPhytotherapy Research, 2005
- Antioxidant Activities of Rosemary, Sage, and Sumac Extracts and Their Combinations on Stability of Natural Peanut OilJournal of Medicinal Food, 2003
- Effect of Rosmarinus officinalis L. aerial parts extract on morphine withdrawal syndrome in micePhytotherapy Research, 2003
- Carnosic Acid, a Component of Rosemary (Rosmarinus officinalis L.), Promotes Synthesis of Nerve Growth Factor in T98G Human Glioblastoma CellsBiological and Pharmaceutical Bulletin, 2003
- Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials.1999
- Medicinal plants and phytotherapy in the Amalfitan Coast, Salerno Province, Campania, Southern ItalyJournal of Ethnopharmacology, 1993